Aegerion Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 92   

Articles published

AEGR 20.20 +1.96 (10.75%)
price chart
Jefferies Upgrades Aegerion Pharma To Buy, Sees Positively Skewed Risk/Reward
In a report published Tuesday, Jefferies analyst Eun K. Yang upgraded the rating on Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) from Hold to Buy, while maintaining the price target at $26.
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)announced that Aegerion board ...  Inside Trade
Earnings Surprise in Focus: Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)  Investor Newswire
Why Aegerion Pharmaceuticals, Inc. Stock Collapsed in October
What: Shares of Aegerion Pharmaceuticals (NASDAQ: AEGR ) , a biopharmaceutical company focused on developing drugs to treat rare diseases, collapsed in October and lost 40% of their value, based on data from S&P Capital IQ, after the company ...
Aegerion Pharmaceuticals (AEGR) to Acquire Myalept from AstraZeneca (AZN ...  StreetInsider.com (subscription)
Aegerion Pharma Buys Drug From AstraZeneca for $325M  Mergers & Acquisitions - The Middle Market
Related articles »  
Stock Report on Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)
[Globe Newswire] Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)(TREND ANALYSIS) a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, today announced ...
Company Shares of Aegerion Pharmaceuticals, Inc. Rally 0.11%  American Trade Journal
Momentum Stocks: Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), Quiksilver ...  Stock Transcript
Aegerion Pharmaceuticals Inc (NASDAQ:AEGR) near 52-week low, short interest ...
Aegerion Pharmaceuticals Inc (NASDAQ:AEGR) (TREND ANALYSIS) shares were traded with a volume more than two times higher than the usual volume.
Large Outflow of Money Witnessed in Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) During the most recent session, the shares traded at 0.07 points or 0.39% higher at $18.05.
Company Shares of Aegerion Pharmaceuticals, Inc. Drops by -4.31%  American Trade Journal
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) Stock Rating Update  Investor Newswire
Aegerion Pharmaceuticals Inc. (AEGR) Hits New 52-week Low During June 29 Session
Aegerion Pharmaceuticals Inc. (AEGR) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $17.86, Aegerion Pharmaceuticals Inc. dropped to $17.73 for a new 52-week low. By the closing bell, the ...
Large Inflow of Money Witnessed in Aegerion Pharmaceuticals, Inc.
Shares of Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) saw an erosion of -0.05 points in recent session. During the trading, the value of each share was $18.07, dropping -0.28%.
Company Shares of Aegerion Pharmaceuticals, Inc. Drops by -0.59%  American Trade Journal
Aegerion Pharmaceuticals Receives Average Recommendation of "Hold" ...  WKRB News
Analyst Price Target Update on Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) stock has received a short term price target of $ 40.83 from 6 Analyst.
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) Analyst Rating Update  American Trade Journal
Stock Update: Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)  Markets Daily
Technical Insights on Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)
[Globe Newswire] Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)(TREND ANALYSIS) a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, announced that ...
Pre-Market Stocks Roundup: Gentex (NASDAQ:GNTX), Aegerion Pharmaceuticals ...
Aegerion Pharmaceuticals, Inc. (AEGR) declared the primary endpoint was achieved in the Company's open-label, multicenter study to evaluate the efficacy and safety of lomitapide in nine Japanese patients with homozygous familial hypercholesterolemia ...